GlassScriptPhysician profile
Andrew Sapthavee
NPI 1972746766
$5,587.60
in general payments reported to CMS, 2019-2025
25 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $141 · 2021: $403 · 2022: $2,674 · 2023: $717 · 2024: $538 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,732.54 | 2019-2025 | Clarifix Cryotherapy Device, Reprocessed Artho Shavers, Scopis Ent |
| Medtronic, INC. | $1,583.57 | 2021-2025 | Novapak, Pteye Parathyroid Detection System, Propel |
| Integra Lifesciences Corporation | $412.84 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Optinose US, INC. | $293.35 | 2023-2025 | |
| Glaxosmithkline, LLC. | $263.50 | 2023-2025 | Nucala |
| Aerin Medical INC. | $255.03 | 2020-2025 | |
| Kerecis Limited | $218.20 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Genzyme Corporation | $177.13 | 2022-2023 | |
| Acera Surgical, INC. | $96.95 | 2022-2024 | Restrata Wound Matrix |
| Phadia US INC. | $80.74 | 2021-2024 | Immunocap |
| Acclarent, INC | $67.94 | 2021-2022 | |
| Ambu INC. | $62.99 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $39.70 | 2019 | |
| Neurent Medical Limited | $38.14 | 2023-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Astrazeneca Pharmaceuticals LP | $37.71 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $36.73 | 2025 | Dupixent |
| Hospira, INC. | $27.21 | 2022 | |
| Aroa Biosurgery Incorporated | $25.77 | 2022 | |
| Ethicon US, LLC | $25.48 | 2024 | Vicryl |
| Bioventus LLC | $22.40 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Otsuka America Pharmaceutical, INC. | $21.83 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.38 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.41 | 2025 | Xhance |
| Hikma Pharmaceuticals USA | $15.91 | 2024 | Ryaltris |
| Olympus America INC. | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Sapthavee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.